Volume | 924,785 |
|
|||||
News | - | ||||||
Day High | 23.03 | Low High |
|||||
Day Low | 22.56 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Corcept Therapeutics Inc | CORT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
22.60 | 22.56 | 23.03 | 22.95 | 22.66 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
11,380 | 924,785 | $ 22.79 | $ 21,073,657 | - | 20.8693 - 34.275 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:24:12 | priorref | 763 | $ 22.95 | USD |
Corcept Therapeutics (CORT) Options Flow Summary
Corcept Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.37B | 103.52M | - | 482.38M | 106.14M | 1.03 | 22.37 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Corcept Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CORT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 23.66 | 23.82 | 22.56 | 23.07 | 758,915 | -0.71 | -3.00% |
1 Month | 24.88 | 26.10 | 22.56 | 24.44 | 773,186 | -1.93 | -7.76% |
3 Months | 23.14 | 26.10 | 20.8693 | 23.28 | 1,127,544 | -0.19 | -0.82% |
6 Months | 28.33 | 33.28 | 20.8693 | 24.71 | 1,165,211 | -5.38 | -18.99% |
1 Year | 22.07 | 34.275 | 20.8693 | 25.49 | 913,079 | 0.88 | 3.99% |
3 Years | 22.68 | 34.275 | 15.825 | 23.16 | 863,731 | 0.27 | 1.19% |
5 Years | 11.90 | 34.275 | 9.55 | 20.15 | 956,184 | 11.05 | 92.86% |
Corcept Therapeutics Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. |